glp 1 drug classification A schematic overview of GLP-1 receptor agonists: classification, GLP-1 receptor agonists | How
Description
Downregulation of GLP-1 and GIP receptor expression by hyperglycemia possible contribution to impaired incretin effects in diabetes
The negative attitude of Novo Nordisk was summed up by Lars Srenson, the company's CEO, who in 2005 argued 'Obesity is primarily a social and cultural problem
Some research suggests potential direct effects on hepatic lipid metabolism and lipoprotein synthesis, though these mechanisms require further investigation
Thus, this promotes the market growth
doi: 10.1152/ajpregu.00123.2015
